Oliver Lagore Vanvalin Investment Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.4K | Buy |
+371
| New | +$37.4K | 0.01% | 283 |
|
|
2024
Q4 | $45.8K | Sell |
513
-95
| -16% | -$8.49K | 0.01% | 259 |
|
|
2024
Q3 | $51K | Buy |
608
+55
| +10% | +$4.61K | 0.01% | 247 |
|
|
2024
Q2 | $42.6K | Sell |
553
-375
| -40% | -$28.9K | 0.01% | 256 |
|
|
2024
Q1 | $63.6K | Sell |
928
-100
| -10% | -$6.85K | 0.02% | 220 |
|
|
2023
Q4 | $59.4K | Buy |
1,028
+136
| +15% | +$7.86K | 0.02% | 202 |
|
|
2023
Q3 | $47.1K | Buy |
892
+81
| +10% | +$4.28K | 0.02% | 244 |
|
|
2023
Q2 | $43.9K | Sell |
811
-158
| -16% | -$8.55K | 0.02% | 263 |
|
|
2023
Q1 | $48.5K | Buy |
969
+150
| +18% | +$7.5K | 0.02% | 192 |
|
|
2022
Q4 | $37.9K | Sell |
819
-16
| -2% | -$740 | 0.02% | 206 |
|
|
2022
Q3 | $32K | Hold |
835
| – | – | 0.02% | 205 |
|
|
2022
Q2 | $31K | Buy |
835
+85
| +11% | +$3.16K | 0.02% | 224 |
|
|
2022
Q1 | $34K | Buy |
+750
| New | +$34K | 0.02% | 203 |
|